FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Atrium Medical Recalls iCast Stent System

Atrium Medical recalls its iCast Covered Stent System after receiving increased customer complaints about the balloon or catheter hub separating from ...

Human Drugs

Doctors Sue FDA Over Ivermectin for Covid

Three doctors sue FDA over the agencys efforts to prevent the use of ivermectin to treat Covid-19.

Human Drugs

Bill to Streamline Generic Drug Approvals

Sens. Hassan and Paul introduce a bill to require FDA to more clearly identify differences between a generic and its reference-listed drug.

Human Drugs

Novartis Gets Expanded OK for Kymriah

FDA grants Novartis accelerated approval for Kymriah (tisagenlecleucel) for treating adult patients with relapsed or refractory follicular lymphoma af...

Federal Register

Coronary Artery Disease Risk Indicators in Class 2

Federal Register notice: FDA classifies coronary artery disease risk indicators using acoustic heart signals into Class 2 (special controls).

Human Drugs

Coordinate on Drug Patent Oversight: Senators

Sens. Cassidy and Hassan call on FDA and the Patent and Trademark Office to better coordinate and communicate on drug patent applications that could d...

Human Drugs

FDA Pulls TG Therapeutics Ukoniq for Safety

FDA says it has pulled its approval of TG Therapeutics Ukoniq for two lymphoma indications due to safety concerns.

Human Drugs

Antimicrobial Susceptibility Test Criteria Site

FDA launches a Web page, required by the 21st Century Cures Act, on antibacterial and antifungal susceptibility test interpretive criteria.

Human Drugs

Breakthrough Therapy Designation for Efanesoctocog Alfa

FDA grants breakthrough therapy designation to Sanofis efanesoctocog alfa to treat hemophilia A.

Human Drugs

Value of FDA Accelerated Approval Not Proven: Researchers

Researchers say CMS too often pays for drugs that received FDA accelerated approval but did not confirm a clinical benefit.